Literature DB >> 17207608

Biochemical characterisation of the CTX-M-14 beta-lactamase.

Yoshikazu Ishii1, Moreno Galleni, Ling Ma, Jean-Marie Frère, Keizo Yamaguchi.   

Abstract

Cefotaxime-resistant Escherichia coli TUM1121 was isolated from an abscess of an 83-year-old patient. The CTX-M-14 gene was located on a 70 kb plasmid. The enzyme was purified and its activity was analysed. CTX-M-14 was poorly active against ceftazidime and aztreonam. Aztreonam behaved as a competitive inhibitor. Among the tested suicide substrates for class A beta-lactamases, sulbactam was a rather good substrate. Tazobactam and clavulanic acid behaved as inactivators. The interactions between clavulanic acid and CTX-M-14 were characterised by progressive inactivation of the beta-lactamase. Carbapenems such as imipenem, meropenem or doripenem did not behave as inactivators of CTX-M-14, however very small k(cat) values were observed. This result shows that CTX-M-14 is able to hydrolyse carbapenems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207608     DOI: 10.1016/j.ijantimicag.2006.09.005

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

2.  Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15.

Authors:  Dandan He; Jiachi Chiou; Zhenling Zeng; Lanping Liu; Xiaojie Chen; Li Zeng; Edward Wai Chi Chan; Jian-Hua Liu; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Kevin E Ruprecht; Timothy Palzkill
Journal:  J Biol Chem       Date:  2013-04-27       Impact factor: 5.157

4.  Comparative Characterization of CTX-M-64 and CTX-M-14 Provides Insights into the Structure and Catalytic Activity of the CTX-M Class of Enzymes.

Authors:  Dandan He; Jiachi Chiou; Zhenling Zeng; Edward Wai-Chi Chan; Jian-Hua Liu; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.

Authors:  Cameron A Brown; Liya Hu; Zhizeng Sun; Meha P Patel; Sukrit Singh; Justin R Porter; Banumathi Sankaran; B V Venkataram Prasad; Gregory R Bowman; Timothy Palzkill
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

Review 6.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

7.  In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.

Authors:  Yoshikazu Ishii; Maki Eto; Yoko Mano; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

8.  Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.

Authors:  David M Boragine; Wanzhi Huang; Lynn H Su; Timothy Palzkill
Journal:  Chembiochem       Date:  2021-12-07       Impact factor: 3.164

9.  Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.

Authors:  Meha P Patel; Bartlomiej G Fryszczyn; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

10.  Characteristics of doripenem: a new broad-spectrum antibiotic.

Authors:  Francisco Alvarez-Lerma; Santiago Grau; Olivia Ferrández
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.